In this study, we demonstrated the driver role of SPHK1 in promoting in vitro migration and invasion as well as lung metastases of bladder cancer in which S1PR-elicited Akt/β-catenin signaling network is the key downstream effector for the mechanism of action. The gene discussed is SPHK1; the disease is urinary bladder cancer.